Introduction The Swedish Agency for Health Technology Assessment and of Social Services (SBU) is commissioned to assess ethical aspects in their health technology assessment (HTA) reports, addition effects economic the examined interventions. For this purpose, a framework systematic evaluation healthcare technologies has been developed used at SBU since 2014. With seven years practice, we decid...

The Pan American Health Organization (PAHO), Regional Office of the World Health Organization (WHO) for the Americas, has tried to promote health technology assessment (HTA) in Latin America for 25 years. A certain awareness of HTA developed in several countries because of these efforts. In the late 1990's, there was a strong movement for health reform in Latin America, and HTA became part of t...

The combination of rising health care costs, efforts to achieve universal or near-universal coverage globally, and growing drive for better outcomes brings an urgent demand to spend health care funds efficiently and in accordance with each country's priorities. A response to such demand requires, first, an understanding of what technologies and interventions (drugs, devices, procedures, diagnos...

Countries in the Balkan region use pharmaco-economic data for decisions about the inclusion of new pharmaceuticals into their positive drug lists, but no predefined frameworks are used and resources for health technology assessment (HTA) are limited. The goal of this analysis is to investigate into possible development directions for the HTA system in the region, and provide some practical reco...

OBJECTIVES The aim of this study was to support health technology assessment (HTA) capacity building in Member States of the European Union with limited experience or without institutionalized HTA. The main output is a Handbook on HTA Capacity Building. METHODS The methods used were worldwide surveys of (i) HTA organizations, (ii) information management units, and (iii) HTA educational progra...

Orphan drugs (ODs) are intended for the diagnosis, prevention, or treatment of rare diseases. Many cancer subtypes, including all childhood cancers, are defined as rare diseases, and over one-third of ODs are now intended to treat oncology indications. However, market access for oncology ODs is becoming increasingly challenging; ODs are prone to significant uncertainty around their cost-effecti...

Abstract Objectives Health technology assessment (HTA) can impact health inequities by informing healthcare priority-setting decisions. This paper presents a novel checklist to guide HTA practitioners looking include equity considerations in their work: the for (ECHTA). The list is pragmatically organized according generic phases and be consulted at each step. Methods A first set of items was b...